CORBEVAX, the NEW SUBPROTEIN vaccine for COVID

2 years ago
57

More and more people are improving their health and getting biologically younger this year with the help of the best professionals | Work with a health coach on a monthly basis, and start improving your health from tomorrow. info@superlongevity.net Services of our professionals: health and longevity consultations, health and longevity research for private and business clients, helping you create a personalized protocol for your needs.
New email for contact: info@superlongevity.net Write us () to know more about one or more of the new protocols: 1) the super longevity protocol;
2) the super immunity protocol;
3) the super energy and mitochondria protocol;
4) the hair loss protocol.
For any other queries, feel free to write to and we'll put you in touch with professionals who work with our network. The costs of the vaccines for COVID-19 are between 10 to 20 dollars, and one that costs around 4 dollars. The price of one shot of one of the most used COVID vaccines in the world has also increased from 15 dollars and 50 cents to 19 dollars and 50 cents, probably just because they think that the vaccine works and so does its value. After almost three years of pandemic and one year after the start of the vaccine roll-out that has dramatically increased the revenue of big pharmaceutical that are now enjoying their billion-dollar profit, and probably would love to continue that way for many years, by insisting the governments to buy their booster shots after booster shots. Finally, a low-cost SARS-COV-2 vaccine that is altruistically manufactured in a traditional way, has been specifically planned to end this vaccine inequality. This vaccine is called Corbevax, it contains a protein subunit of the coronavirus and is manufactured like how the hepatitis B vaccine has been manufactured for decades. It is developed by the Indian biotechnology and biopharmaceutical company, Biological E in collaboration with Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas. The Biological E company has estimated that the vaccine would cost around 3 US dollars per dose, and may even cost around 5 dollars for two doses in India. According to the manufacturers, the vaccine is not patented, which means that other countries can manufacture the vaccine in order for it to be available for everybody. After phase 3 clinical trials involving more than three thousand subjects, the vaccine was found to be safe and more than ninety percent effective against the ancestral Wuhan strain, and more than eighty percent effective against the delta strain. None of the subjects who took Corbevax had serious adverse reactions. Corbevax also had fifty percent fewer adverse events than Covishield. The effectiveness of the vaccine is still being studied. For now this is all the information we have gathered. Please check the links that are written in the description for your reference. More details about the vaccine will come up in the following months, and we would be happy to share them with you.+

https://www.texaschildrens.org/texas-children%E2%80%99s-hospital-and-baylor-college-medicine-covid-19-vaccine-technology-secures-emergency

https://www.biologicale.com/news.html

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/view-to-vaccinate-the-world-we-need-to-look-beyond-mrna/articleshow/88823334.cms

https://www.fiercepharma.com/pharma/pfizer-eyes-higher-covid-19-vaccine-prices-after-pandemic-exec-analyst

https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-moderna-raises-prices-its-covid-19-vaccines-eu-ft-2021-08-01/

https://www.ft.com/content/d415a01e-d065-44a9-bad4-f9235aa04c1a

Loading comments...